Automating Cell-Based Assays to Determine Viral Vector Titer – Oxford Biomedica & Hamilton Robotics

In this video, Oxford Biomedica, an innovative global gene and cell therapy company with operations in the UK and US, describes the automation of an assay requiring a 10-day cell-based workflow, using an integrated Hamilton Microlab STAR liquid handler and CECULA's Graphical User Interface (GUI).

- Dr. Nicholas Clarkson. VP of Research at Oxford Biomedica
- Dr. Andre Raposo. Director of Analytics, Platform Research at Oxford Biomedica
- Dr. Gabriela Boza-Moran. Field Marketing Team Leader at Hamilton Robotics